Evotec (EVO) said Wednesday it appointed Ingrid Muller as chief operating officer, effective May 1.
Muller has more than 20 years of experience in international leadership in the life sciences industry. She most recently served as vice president portfolio strategy and execution at CureVac.
In her new role, she will oversee the company's global operations and implementation of the Horizon initiative.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.